Yvonne Lentz is a distinguished leader in the field of biotechnology, currently serving as the Cell Therapy Process Development Strategic Leader at Genentech, a member of the Roche Group. With over 20 years of extensive experience in biologics and both autologous and allogenic cell therapies,...
Yvonne Lentz is a distinguished leader in the field of biotechnology, currently serving as the Cell Therapy Process Development Strategic Leader at Genentech, a member of the Roche Group. With over 20 years of extensive experience in biologics and both autologous and allogenic cell therapies, Yvonne has established herself as a pivotal figure in the commercialization of innovative therapeutic products. Her current role involves spearheading late-stage individualized and cell therapy process development strategies, which are crucial for advancing Roche Genentech's diverse cancer vaccine and cell therapy programs.
Yvonne's expertise encompasses a broad spectrum of skills, including clinical demand and supply management, drug product formulation, and process validation. She is adept at navigating the complexities of cell therapy, ensuring that robust and scalable processes are in place for successful technical transfers and commercialization. Her strategic vision is complemented by her hands-on experience in project management, where she has consistently driven innovation while fostering a culture of collaboration within globally matrixed cross-functional teams.
Key projects under Yvonne's leadership include the development of cutting-edge cell therapy platforms that not only enhance therapeutic efficacy but also improve patient outcomes. Her commitment to people and team development is evident in her mentorship of emerging leaders in the field, empowering them to contribute to the rapidly evolving landscape of biotechnology. As a creative and dynamic director, Yvonne continues to push the boundaries of what's possible in cell therapy, positioning Genentech at the forefront of the industry and making significant strides in the fight against cancer.
